New drug aims to stop kidney rejection
Disease control
Not yet recruiting
This early study tests a new medicine called TNX-1500 in 5 people who get a kidney transplant. The goal is to see if it is safe and can help prevent the body from rejecting the new kidney. Participants will be followed for one year to check for side effects and signs of rejection…
Phase: PHASE2 • Sponsor: Ayman Al Jurdi, MD • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC